Loading...
OTCM
STSN
Market cap282kUSD
Dec 05, Last price  
0.00USD
1D
-21.95%
1Q
-71.43%
Jan 2017
-84.00%
IPO
-98.93%
Name

Stemsation International Inc

Chart & Performance

D1W1MN
OTCM:STSN chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
53.28%
Rev. gr., 5y
%
Revenues
0k
00003,3750003,236217,075000
Net income
-87k
L-80.10%
-26,638-447,356-267,056-60,107-133,762-26,720-30,042-29,582-836,294-1,045,796-1,154,069-438,478-87,272
CFO
-48k
L-30.74%
-6,588-232,175-120,629-27,511-150,233-2,4110-376,501-685,439-765,703-69,091-47,854

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

StemSation International, Inc. develops, manufactures, and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body. It offers StemRCM, a dietary supplement that supports stem cells ability to repair, renew, and restore tissues and organ function through healthy stem cell release, circulation, and migration. The company sells its products through independent wellness advocates directly to consumers. StemSation International, Inc. is headquartered in Boca Raton, Florida.
IPO date
Jan 28, 2008
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT